MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejmech.2026.119350

Медицинская библиотека · European journal of medicinal chemistry · 2026

Substituted methyl acridone-carboxylate derivatives as CD1/CD2 dual-targeting HDAC6 inhibitors to ameliorate the pathological phenotype of Alzheimer's disease.

Ye Jianan, Yin Sijia, Lin Yutao, Yang Shuhui, Ma Lieen, Wang Yang, Gao Kangyang, Wang Yule, Yang Xinhang, Yang Zhichao, Wang Ning, Liu Hao, Xu Shujun, Cui Wei, Zhang Bin

СтатьяПеревод в очереди

Аннотация

Histone deacetylase 6 (HDAC6) has emerged as a promising target for Alzheimer' disease (AD). Although most reported HDAC6 inhibitors were designed to target CD2 catalytic domain, recent studies highlighted the functional importance of CD1 domain for the regulation of AD-related substrates. In this study, a series of substituted methyl acridone-carboxylate derivatives bearing a methyl ester moiety were discovered as CD1/CD2 dual-targeting HDAC6 inhibitors. The leading compound 6c could direct bind to HDAC6, and selectively inhibits HDAC6 with a high affinity in vitro. Molecular docking analysis revealed that 6c forms non-chelating coordination interactions with the zinc ions in both CD1 and CD2 domains of HDAC6. 6c inhibited Aβ oligomer-induced microtubule depolymerization and microglial phagocytic impairments in vitro. Furthermore, 6c effectively prevented HDAC6-driven α-tubulin and Hsp90 deacylation, as well as cognitive impairments in Aβ1-42 oligomer-treated mice. Combined with the acceptable physicochemical properties and promising biosafety of 6c, this study suggested that substituted methyl acridone-carboxylate derivatives, as CD1/CD2 dual-targeting HDAC6 inhibitors, might be developed as a novel lead drug for the treatment of AD.

Для цитирования: Ye Jianan, Yin Sijia, Lin Yutao, Yang Shuhui, Ma Lieen, Wang Yang, Gao Kangyang, Wang Yule, Yang Xinhang, Yang Zhichao, Wang Ning, Liu Hao, Xu Shujun, Cui Wei, Zhang Bin. Substituted methyl acridone-carboxylate derivatives as CD1/CD2 dual-targeting HDAC6 inhibitors to ameliorate the pathological phenotype of Alzheimer's disease.. European journal of medicinal chemistry. 2026. DOI: 10.1016/j.ejmech.2026.119350.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.